|
🐜
|
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis
30 auth.
L. Coates,
A. Kavanaugh,
P. Mease,
E. Soriano,
Maria Laura Acosta-Felquer,
A. Armstrong,
W. Bautista-Molano,
W. Boehncke,
Willemina Campbell,
A. Cauli,
L. Espinoza,
O. FitzGerald,
D. Gladman,
A. Gottlieb,
P. Helliwell,
...
M. Husni,
T. Love,
E. Lubrano,
N. McHugh,
P. Nash,
A. Ogdie,
A. Orbai,
Andrew Parkinson,
D. O'Sullivan,
C. Rosen,
S. Schwartzman,
E. Siegel,
S. Toloza,
William Tuong,
C. Ritchlin
|
9 |
2016 |
9
🐜
|
|
🐜
|
The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclophosphamide
22 auth.
F. Houssiau,
C. Vasconcelos,
D. D'cruz,
G. Sebastiani,
E. Garrido,
M. Danieli,
D. Abramovicz,
D. Blockmans,
A. Cauli,
H. Direşkeneli,
...
M. Galeazzi,
A. Gül,
Y. Levy,
P. Petera,
R. Popović,
R. Petrovic,
R. Sinico,
R. Cattaneo,
J. Font,
G. Depresseux,
J. Cosyns,
R. Cervera
|
8 |
2009 |
8
🐜
|
|
🐜
|
Consensus on a core set of domains for psoriatic arthritis.
25 auth.
D. Gladman,
P. Mease,
V. Strand,
P. Healy,
P. Helliwell,
O. FitzGerald,
A. Gottlieb,
G. Krueger,
P. Nash,
C. Ritchlin,
W. Taylor,
A. Adebajo,
J. Braun,
A. Cauli,
S. Carneiro,
...
E. Choy,
B. Dijkmans,
L. Espinoza,
D. M. van der Heijde,
E. Husni,
E. Lubrano,
D. Mcgonagle,
A. Qureshi,
E. Soriano,
J. Zochling
|
8 |
2007 |
8
🐜
|
|
🐜
|
The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project)
37 auth.
P. Helliwell,
O. FitzGerald,
J. Fransen,
D. Gladman,
Gerald G Kreuger,
K. Callis-Duffin,
N. McHugh,
P. Mease,
V. Strand,
R. Waxman,
V. Azevedo,
A. Beltran ostos,
S. Carneiro,
A. Cauli,
L. Espinoza,
...
J. Flynn,
N. Hassan,
P. Healy,
E. Kerzberg,
Y. Lee,
E. Lubrano,
A. Marchesoni,
H. Marzo-Ortega,
G. Porru,
Elvia G Moreta,
P. Nash,
H. Raffayova,
R. Ranza,
S. Raychaudhuri,
E. Roussou,
R. Scarpa,
Y. Song,
E. Soriano,
P. Tak,
I. Újfalussy,
K. de Vlam,
J. Walsh
|
8 |
2012 |
8
🐜
|
|
🐜
|
Molecular Portraits of Early Rheumatoid Arthritis Identify Clinical and Treatment Response Phenotypes
29 auth.
M. Lewis,
M. Barnes,
K. Blighe,
K. Goldmann,
S. Rana,
J. Hackney,
N. Ramamoorthi,
C. John,
David S. Watson,
S. Kummerfeld,
R. Hands,
S. Riahi,
V. Rocher-Ros,
F. Rivellese,
F. Humby,
...
S. Kelly,
M. Bombardieri,
N. Ng,
M. Dicicco,
D. M. van der Heijde,
R. Landewé,
A. H. M. van der Helm-van Mil,
A. Cauli,
I. McInnes,
C. Buckley,
E. Choy,
P. Taylor,
M. Townsend,
C. Pitzalis
|
8 |
2019 |
8
🐜
|
|
🐜
|
Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
25 auth.
F. Humby,
M. Lewis,
N. Ramamoorthi,
J. Hackney,
Michael R. Barnes,
M. Bombardieri,
Francesca Setiadi,
S. Kelly,
F. Bene,
M. D. Cicco,
S. Riahi,
V. Rocher-Ros,
N. Ng,
Ilias Lazorou,
R. Hands,
...
D. Heijde,
R. Landewé,
A. Mil,
A. Cauli,
I. McInnes,
C. Buckley,
Ernest Choy,
P. Taylor,
M. Townsend,
C. Pitzalis
|
7 |
2019 |
7
🐜
|
|
🐜
|
Reduction of synovial inflammation after anti-CD4 monoclonal antibody treatment in early rheumatoid arthritis.
10 auth.
P. Tak,
P. A. van der Lubbe,
A. Cauli,
M. Daha,
T. Smeets,
P. Kluin,
...
A. Meinders,
G. Yanni,
G. Panayi,
F. Breedveld
|
7 |
1995 |
7
🐜
|
|
🐜
|
Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial
46 auth.
F. Humby,
P. Durez,
M. Buch,
M. Lewis,
H. Rizvi,
F. Rivellese,
A. Nerviani,
G. Giorli,
A. Mahto,
C. Montecucco,
B. Lauwerys,
N. Ng,
P. Ho,
M. Bombardieri,
V. Romão,
...
P. Verschueren,
S. Kelly,
P. Sainaghi,
N. Gendi,
B. Dasgupta,
A. Cauli,
P. Reynolds,
J. Cañete,
R. Moots,
P. Taylor,
C. Edwards,
J. Isaacs,
P. Sasieni,
E. Choy,
C. Pitzalis,
C. Thompson,
S. Bugatti,
M. Bellan,
M. Congia,
C. Holroyd,
A. Pratt,
J. E. Cabral da Fonseca,
L. White,
Louise Warren,
Joanna Peel,
R. Hands,
L. Fossati-Jimack,
G. Hadfield,
G. Thorborn,
J. Ramírez,
R. Celis
|
7 |
2021 |
7
🐜
|
|
🐜
|
Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial
62 auth.
F. Rivellese,
Anna E. A. Surace,
K. Goldmann,
E. Sciacca,
C. Çubuk,
G. Giorli,
C. John,
A. Nerviani,
L. Fossati-Jimack,
G. Thorborn,
Manzoor Ahmed,
E. Prediletto,
S. Church,
Briana M. Hudson,
S. Warren,
...
P. McKeigue,
F. Humby,
M. Bombardieri,
Michael R. Barnes,
Costantino Pitzalis,
F. Rivellese,
A. Nerviani,
L. Fossati-Jimack,
F. Humby,
P. Durez,
M. Buch,
H. Rizvi,
A. Mahto,
C. Montecucco,
B. Lauwerys,
N. Ng,
P. Ho,
V. Romão,
João Eurico Cabral da Fonseca,
P. Verschueren,
S. Kelly,
P. Sainaghi,
N. Gendi,
B. Dasgupta,
A. Cauli,
P. Reynolds,
J. Cañete,
J. Ramírez,
R. Celis,
R. Moots,
P. Taylor,
C. Edwards,
J. Isaacs,
P. Sasieni,
E. Choy,
C. Thompson,
S. Bugatti,
M. Bellan,
M. Congia,
C. Holroyd,
A. Pratt,
L. White,
Louise Warren,
Joanna Peel,
R. Hands,
G. Hadfield,
Costantino Pitzalis
|
7 |
2022 |
7
🐜
|
|
🐜
|
Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations
13 auth.
G. Sanna,
M. Piga,
J. Terryberry,
M. T. Peltz,
S. Giagheddu,
L. Satta,
Alaa Ahmed,
A. Cauli,
C. Montaldo,
Giuseppe Passiu,
...
James B. Peter,
Y. Shoenfeld,
Alessandro Mathieu
|
7 |
2000 |
7
🐜
|
|
🐢
|
Telemedicine for patients with rheumatic diseases: Systematic review and proposal for research agenda.
M. Piga,
Ignazio Cangemi,
A. Mathieu,
A. Cauli
|
7 |
2017 |
7
🐢
|
